Racheal Adams to participate in FDA’s Compounding Quality Center of Excellence Virtual Conference

SCA Pharma Director of Corporate Quality Racheal Adams, will join leading industry experts for the FDA’s 2021 Compounding Quality Center of Excellence Virtual Conference titled “Culture of Quality” being held September 13-15. The virtual conference will bring together outsourcing facilities, regulators and industry leadership to engage on emerging industry topics and best practices to improve…

How to Properly Decipher an FDA Form 483

In your role, you’re likely responsible for vetting potential supplier partners on behalf of your hospital or GPO. You’ve undoubtedly been asked to request each Form 483 and decipher the unnecessarily complex jargon of the FDA. Mosaic by design, it is extremely important that you know how to properly interpret an FDA Form 483. According…

sca pharma facilities

The Advantages of 503B Compounding

Due to the important role of healthcare in maintaining the health of the general public in society, it is highly regulated with plenty of governmental oversight. The Pharmaceutical Research and Manufacturers of America have estimated that close to 3.6 billion prescriptions are dispensed each year in the United States. It is estimated that 30 to…